Go Deep
Nidan Laboratories and Healthcare Limited
Nidan Laboratories and Healthcare Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 18,770 | 22.6 | 0.67 | 0.16 | 33.00 |
| Oct 2026 | 25,211 | 30.6 | 0.27 | 0.16 | 13.25 |
Nidan Laboratories and Healthcare Limited Quarterly Results
Quarterly data isn't available for this company right now.
Nidan Laboratories and Healthcare Limited Revenue & Profit: Last 4 Years
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | 245,275,000.0 | 241,774,000.0 | 242,659,000.0 | 296,601,000.0 |
| Net Profit | 19,769,000.0 | -32,324,000.0 | 35,396,000.0 | 26,629,000.0 |
| EPS | 1.4 | -2.3 | 2.5 | 2.3 |
Nidan Laboratories and Healthcare Limited Balance Sheet
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Total Assets | 829,411,000.0 | 825,506,000.0 | 844,016,000.0 | 884,790,000.0 |
| Total Liabilities | 147,581,000.0 | 163,445,000.0 | 149,632,000.0 | 225,801,000.0 |
| Total Equity | 681,830,000.0 | 662,061,000.0 | 694,384,000.0 | 658,989,000.0 |
Owes vs Owns
Nidan Laboratories and Healthcare Limited owed ₹0.18 for every ₹1 it owned in Mar 2025, down from ₹0.26 in Mar 2022.
| Period | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Owes vs Owns | 0.18× | 0.20× | 0.18× | 0.26× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Nidan Laboratories and Healthcare Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2025
Cash & short-term investments 2.3%Receivables 1.5%Inventory 0.7%Fixed assets (tangible) 24.8%Long-term investments 24.1%Other assets 46.6%
How it's funded — Mar 2025
Short-term debt 8.7%Long-term debt 4.7%Payables 1.2%Other liabilities 3.2%Shareholders' equity 82.2%
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 1.9 | 2.8 | 8.4 | 8.1 |
| Receivables | 1.3 | 0.5 | 6.0 | 5.4 |
| Inventory | 0.5 | 0.3 | 0.4 | 0.2 |
| Fixed assets (tangible) | 20.6 | 22.2 | 29.9 | 32.4 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 20.0 | 0.0 | 0.0 | 29.5 |
| Other assets | 38.6 | 56.7 | 39.7 | 12.8 |
| Liabilities & equity | ||||
| Short-term debt | 7.2 | 8.1 | 6.2 | 9.9 |
| Long-term debt | 3.9 | 4.3 | 4.8 | 9.4 |
| Payables | 1.0 | 0.7 | 0.2 | 1.1 |
| Other liabilities | 2.7 | 3.2 | 3.8 | 2.1 |
| Shareholders' equity | 68.2 | 66.2 | 69.4 | 65.9 |
| Net tangible assets | 68.2 | 66.2 | 69.4 | 65.9 |
Nidan Laboratories and Healthcare Limited Cash Flow
| Line Item | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Operating Activities | 22,764,000.0 | 55,199,000.0 | 109,691,000.0 | 78,276,000.0 |
| Investing Activities | -2,195,000.0 | -106,026,000.0 | -2,853,000.0 | -357,418,000.0 |
| Financing Activities | -30,074,000.0 | -4,868,000.0 | -103,658,000.0 | 287,191,000.0 |